SVP

EQS-News: Abivax reports 2023 financial results and operational update

Retrieved on: 
Wednesday, April 10, 2024

Total number of employees at the end of December 2023 was 61 and significantly increased compared to 2022, due to the implementation of the U.S. and European operational infrastructure.

Key Points: 
  • Total number of employees at the end of December 2023 was 61 and significantly increased compared to 2022, due to the implementation of the U.S. and European operational infrastructure.
  • Cash position (including other financial assets of EUR 9.0M) at the end of 2023 was EUR 261.0M, compared to EUR 27.0M at the end of 2022.
  • A webcast will be organized on Monday, April 8, 2024, at 2:30 p.m. CEST (8:30 a.m. EST) following the announcement of the 2023 yearly results.
  • The Abivax management will give an overview of the Company’s 2023 highlights and projects going forward, followed by a live Q&A session.

APA Corporation Announces Updates to Executive Leadership

Retrieved on: 
Tuesday, April 9, 2024

HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) has announced updates to its executive leadership team to coincide with a restructuring of its development function and the integration of the recently closed acquisition of Callon Petroleum.

Key Points: 
  • HOUSTON, April 09, 2024 (GLOBE NEWSWIRE) -- APA Corporation (Nasdaq: APA) has announced updates to its executive leadership team to coincide with a restructuring of its development function and the integration of the recently closed acquisition of Callon Petroleum.
  • “Building on the momentum of our recently closed acquisition, we are updating our leadership structure to better align with the evolving needs of our business,” said John J. Christmann, APA chief executive officer.
  • He currently serves on the board of Khalda Petroleum Company, a joint venture between APA subsidiary Apache Corporation and Egypt Petroleum Company.
  • Castlen Kennedy has been promoted to senior vice president, Corporate Affairs and Marketing reporting to Mark Maddox, executive vice president, Administration.

New Jersey Devils and Prudential Center announce extended partnership with Verizon

Retrieved on: 
Tuesday, April 9, 2024

NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- The New Jersey Devils, Prudential Center, and Verizon announced today a multi-year extension of their partnership featuring new and innovative technology for wireless connectivity and retail convenience to enhance the fan experience and improve arena operations.

Key Points: 
  • NEW YORK, April 09, 2024 (GLOBE NEWSWIRE) -- The New Jersey Devils, Prudential Center, and Verizon announced today a multi-year extension of their partnership featuring new and innovative technology for wireless connectivity and retail convenience to enhance the fan experience and improve arena operations.
  • Through this extended partnership, Verizon is deploying Verizon 5G Ultra Wideband, Verizon Private 5G Network and Wi-Fi 6/6E to give Prudential Center the ability to host a wide range of large-scale events, concerts and games with a more efficient and reliable network and fast connectivity.
  • The improved wireless connectivity will also change the way fans experience games and live events in the arena and through the Devils and Prudential Center Mobile App, Powered by Verizon.
  • “We are thrilled to extend our partnership with Verizon, a New Jersey-based company, and lay the foundation for the way fans view and experience Devils home games and other events at Prudential Center,” said Sasha Puric, Chief Technology Officer, HBSE.

Signati™ Medical Enrolls First Patient in Groundbreaking Sealed Vasectomy Procedure Trial

Retrieved on: 
Tuesday, April 9, 2024

This significant reduction in procedure time holds immense promise for improving patient experience and potentially increasing vasectomy rates.

Key Points: 
  • This significant reduction in procedure time holds immense promise for improving patient experience and potentially increasing vasectomy rates.
  • Principal Investigator Dr. Matthew Mutter of LSU Medical Center commented on the first patient enrollment: "The Signati Separo™ worked flawlessly.
  • The Sealed Vasectomy Procedure (SVP)™ represents the first major advancement in vasectomy technology in over 40 years.
  • The SVP is a minimally invasive, procedure that offers several potential benefits over traditional vasectomy techniques, including:
    The IDE trial is a prospective study designed to evaluate the safety and efficacy of the Signati Separo™ for vasectomy.

FullBloom Expands Leadership Team with Key Appointments

Retrieved on: 
Tuesday, April 9, 2024

She will plan and direct all aspects of the organization’s sales, including go-to-market strategy, new customer acquisitions, key account growth and overall pipeline management.

Key Points: 
  • She will plan and direct all aspects of the organization’s sales, including go-to-market strategy, new customer acquisitions, key account growth and overall pipeline management.
  • DeVore is an experienced healthcare services executive who worked in leadership roles spanning different sectors of healthcare and within organizations of various scale and structure.
  • The leadership team expansion comes on the heels of FullBloom’s acquisition of EmpowerU , a premier provider of evidence-based programs that improve student motivation, behaviors, and mental health.
  • Addressing the urgent mental health crisis facing America’s students is a top priority for FullBloom as it works to deliver critical services that support students academically, emotionally, and behaviorally.

Clartias Chief AI Officer Rex Briggs to Keynote Possible

Retrieved on: 
Tuesday, April 9, 2024

Cincinnati, Ohio, April 08, 2024 (GLOBE NEWSWIRE) -- Claritas ®, a data-driven marketing leader that leverages a proprietary identity graph to help marketers achieve superior ROI, today announced that its Chief AI Officer Rex Briggs will deliver a keynote discussion at Possible 2024.

Key Points: 
  • Cincinnati, Ohio, April 08, 2024 (GLOBE NEWSWIRE) -- Claritas ®, a data-driven marketing leader that leverages a proprietary identity graph to help marketers achieve superior ROI, today announced that its Chief AI Officer Rex Briggs will deliver a keynote discussion at Possible 2024.
  • In addition to Briggs, other speakers at Possible 2024 include: Linda Boff, GE Chief Marketing Officer VP, Learning & Culture President, GE Foundation; Esi Eggleston Bracey, Chief Growth & Marketing Officer, Unilever; Tariq Hassan, Chief Marketing & Customer Experience Officer, McDonald's Corporation; Diana Haussling, SVP - GM Consumer Experience and Growth, Colgate-Palmolive;  Linda Lee, Chief Marketing Officer, Campbell’s Soup; Frank Cooper III, Chief Marketing Officer, Visa;  Remi Kent, Chief Marketing Officer, Progressive Insurance; David Droga, Chief Executive Officer, Accenture Song; Soyoung Kang, Chief Marketing Officer, Eos; Dana Marineau, Chief Marketing Officer, Rakuten; Bozoma Saint John, Hall of Fame Inducted Marketing Executive, Author, and Entrepreneur; Jaime Teevan, Chief Scientist, Microsoft and Gary Vaynerchuk, Chairman, VaynerX.
  • During Briggs’ work with the Ad Council, he discovered ArtsAI and experimented with its patented AI Personalization technology.
  • In his latest book, “The AI Conundrum” (MIT Press), Briggs and co-author Caleb Briggs explore why artificial intelligence’s strengths are also AI’s weaknesses – and how businesses can effectively apply AI to improve their business.

NRSInsights’ March 2024 Retail Same-Store Sales Report

Retrieved on: 
Monday, April 8, 2024

NEWARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- NRSInsights, a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for March 2024.

Key Points: 
  • March same-store sales jumped 7.2% year-over-year, the highest rate of increase since June 2023
    NEWARK, N.J., April 08, 2024 (GLOBE NEWSWIRE) -- NRSInsights , a provider of sales data and analytics drawn from retail transactions processed through the National Retail Solutions (NRS) point-of-sale (POS) platform, today announced comparative same-store sales results for March 2024.
  • (Same-store sales, unit sales, transactions, and average price data throughout this release refer to March 2024 unless otherwise noted.
  • Same-store sales per calendar day in February 2024 had increased 7.4% compared to January 2024.
  • The NRSInsights monthly Same-Store Retail Sales Reports are intended to provide timely topline data reflective of sales at NRS’ network of independent, predominantly urban, retail stores.

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Zymeworks Inc. - ZYME

Retrieved on: 
Monday, April 8, 2024

NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME).

Key Points: 
  • NEW YORK, April 08, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Zymeworks Inc. (“Zymeworks” or the “Company”) (NASDAQ: ZYME).
  • 7980
    The investigation concerns whether Zymeworks and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

Synaptics Astra™ AI-Native IoT Platform Launches with SL-Series Embedded Processors and Machina Foundation Series Development Kit

Retrieved on: 
Monday, April 8, 2024

SAN JOSE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA ) today launched the Synaptics Astra platform with the SL-Series of embedded AI-native Internet of Things (IoT) processors and the Astra MachinaTM Foundation Series development kit.

Key Points: 
  • SAN JOSE, Calif., April 08, 2024 (GLOBE NEWSWIRE) -- Synaptics® Incorporated (Nasdaq: SYNA ) today launched the Synaptics Astra platform with the SL-Series of embedded AI-native Internet of Things (IoT) processors and the Astra MachinaTM Foundation Series development kit.
  • The family of embedded processors provides industry-leading compute capability at power-consumption levels that enable a wide range of consumer, enterprise, and industrial edge IoT applications.
  • The Astra Machina Foundation Series development kit supports the SL-Series.
  • The Astra Machina Foundation Series development kit will be available in Q2, 2024.

TScan Therapeutics Appoints Seasoned Hematology and Oncology Expert Chrystal U. Louis, M.D., M.P.H., as Chief Medical Officer

Retrieved on: 
Monday, April 8, 2024

Dr. Louis has extensive experience in hematology and oncology drug development, with a track record of success in clinical development, medical affairs, and commercialization.

Key Points: 
  • Dr. Louis has extensive experience in hematology and oncology drug development, with a track record of success in clinical development, medical affairs, and commercialization.
  • “We are excited to welcome Chrystal to TScan at this critical time as we continue to progress both clinical-stage programs in heme malignancies and solid tumors.
  • “I look forward to working with Chrystal as we strive to realize the full potential of our pipeline.
  • Prior to joining TScan, Dr. Louis was the SVP of hematology clinical development at Zentalis Pharmaceuticals.